Cell Reports Medicine (Oct 2020)

Unacylated-Ghrelin Impairs Hippocampal Neurogenesis and Memory in Mice and Is Altered in Parkinson’s Dementia in Humans

  • Amanda K.E. Hornsby,
  • Luke Buntwal,
  • Maria Carla Carisi,
  • Vanessa V. Santos,
  • Fionnuala Johnston,
  • Luke D. Roberts,
  • Martina Sassi,
  • Mathieu Mequinion,
  • Romana Stark,
  • Alex Reichenbach,
  • Sarah H. Lockie,
  • Mario Siervo,
  • Owain Howell,
  • Alwena H. Morgan,
  • Timothy Wells,
  • Zane B. Andrews,
  • David J. Burn,
  • Jeffrey S. Davies

Journal volume & issue
Vol. 1, no. 7
p. 100120

Abstract

Read online

Summary: Blood-borne factors regulate adult hippocampal neurogenesis and cognition in mammals. We report that elevating circulating unacylated-ghrelin (UAG), using both pharmacological and genetic methods, reduced hippocampal neurogenesis and plasticity in mice. Spatial memory impairments observed in ghrelin-O-acyl transferase-null (GOAT−/−) mice that lack acyl-ghrelin (AG) but have high levels of UAG were rescued by acyl-ghrelin. Acyl-ghrelin-mediated neurogenesis in vitro was dependent on non-cell-autonomous BDNF signaling that was inhibited by UAG. These findings suggest that post-translational acylation of ghrelin is important to neurogenesis and memory in mice. To determine relevance in humans, we analyzed circulating AG:UAG in Parkinson disease (PD) patients diagnosed with dementia (PDD), cognitively intact PD patients, and controls. Notably, plasma AG:UAG was only reduced in PDD. Hippocampal ghrelin-receptor expression remained unchanged; however, GOAT+ cell number was reduced in PDD. We identify UAG as a regulator of hippocampal-dependent plasticity and spatial memory and AG:UAG as a putative circulating diagnostic biomarker of dementia.

Keywords